Cell Therapeutics shuts Italian facility while pinning hopes on pixantrone
This article was originally published in Scrip
Executive Summary
Cell Therapeutics (CTI) has failed to find a buyer for its Italian R&D unit and is closing the facility in Bresso, near Milan.